L26/P-124 Does oocyte yield predict blastocyst chromosomal competence in young women undergoing assisted reproduction? A retrospective analysis of PGT-A cycles
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.460 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von H. Bandari und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Study question In women under 35years undergoing assisted reproduction with blastocyst biopsy, does oocyte number influence blastocyst chromosomal status, implantation rates, and pregnancy outcomes overall success? Summary answer Among women under 35 years,blastocyst chromosomal competence and reproductive outcomes were similar across oocyte yields,with only a weak association for lower oocyte numbers. What is known already In younger women, the principal clinical concern is not excessive ovarian response but low oocyte and blastocyst numbers, where prognosis becomes uncertain. While higher oocyte yield generally increases embryo availability without compromising chromosomal competence, lower oocyte yield may be associated with fewer euploid embryos and limited reproductive options. The role of preimplantation genetic testing for aneuploidy (PGT-A) in young women remains controversial, highlighting the need to understand whether oocyte yield meaningfully predicts blastocyst chromosomal status and downstream reproductive outcomes rather than driving intervention-based decisions. Study design, size, duration This retrospective cohort study analysed assisted reproduction cycles with blastocyst biopsy performed between 2014 and 2024 at a single private fertility centre. Only women aged <35 years were included. Anti-Müllerian hormone (AMH) was not analysed. Outcomes were evaluated based on maternal age, oocyte yield,blastocyst development,and chromosomal status. PGT-A was performed primarily due to a history of recurrent implantation failure (RIF). Outcomes were compared across four groups stratified by the number of oocytes retrieved. Participants/materials, setting, methods All participants underwent standardized controlled ovarian stimulation followed by ICSI. Blastocysts were biopsied at the blastocyst stage and analysed using next-generation sequencing. Elective single euploid blastocyst transfer was performed in all cases. Patients were categorised by oocyte yield: <5 (n = 79), 6–10 (n = 251), 11–15 (n = 213), and >15 (n = 189). Outcomes assessed included blastocyst formation rate, euploidy and aneuploidy rates, implantation rate, miscarriage rate, and live birth rate. Main results and the role of chance Blastocyst formation rates were comparable across oocyte yield groups (53%, 56%, 56%, and 50%, respectively; p > 0.05). Euploidy rates ranged from 47% to 52%, with no significant differences between groups (p > 0.05). A weak trend toward lower euploidy was observed in the <5 oocyte group compared with the 6–10 oocyte group (OR ∼0.8, 95% CI crossing unity), without statistical significance. Following elective single euploid blastocyst transfer, implantation, miscarriage, and live birth rates were similar across oocyte yield categories (live birth rates: 76%, 75%, 75%, and 70%; p > 0.05). Using the 6–10 oocyte group as reference, the odds of live birth did not differ significantly for <5 oocytes (OR ∼0.9, 95% CI crossing unity), 11–15 oocytes (OR ∼1.0), or > 15 oocytes (OR ∼0.8). Confidence intervals overlapped unity across all comparisons, indicating no clinically meaningful association between oocyte yield and live birth once a euploid embryo was available. From a clinical perspective, these findings suggest that while lower oocyte yield may limit embryo numbers, it does not independently predict poorer chromosomal competence or per-transfer reproductive potential in young women. Limitations, reasons for caution The retrospective, single-centre design limits generalisability. Only young women undergoing PGT-A—primarily for RIF—were included, and cumulative live birth rates were not assessed. These findings should not be interpreted as justification for routine PGT-A use in young women. Wider implications of the findings In young women, oocyte quantity alone is a limited predictor of embryo chromosomal competence. Counselling should emphasize embryo availability and clinical context rather than oocyte number alone. PGT-A use should remain individualized and cautious, guided by patient history instead of oocyte yield when making assisted reproduction treatment decisions overall. Trial registration number No
Zitieren
APA
Bandari, H., Mantravadi, K., & Gedela, D. (2026). L26/P-124 Does oocyte yield predict blastocyst chromosomal competence in young women undergoing assisted reproduction? A retrospective analysis of PGT-A cycles. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.460
Vancouver
Bandari H, Mantravadi K, Gedela D. L26/P-124 Does oocyte yield predict blastocyst chromosomal competence in young women undergoing assisted reproduction? A retrospective analysis of PGT-A cycles. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.460
BibTeX
@article{Bandari2026,
author = {Bandari, H. and Mantravadi, K.C. and Gedela, D.R.},
title = {L26/P-124 Does oocyte yield predict blastocyst chromosomal competence in young women undergoing assisted reproduction? A retrospective analysis of PGT-A cycles},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.460}
}
EUVIMED